Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells

Cancer Research

Volumn 64, Issue 3, 2004, Pages 985-993

  Rossignol, Rodrigue ^a   Gilkerson, Robert ^a   Aggeler, Robert ^a   Yamagata, Kunihiro ^a   Remington, S James ^a   Capaldi, Roderick A ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MITOCHONDRIAL DNA;

ARTICLE; BIOSENSOR; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENERGY; FEMALE; GLYCOLYSIS; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRION; MOLECULAR DYNAMICS; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PHENOMENOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR REGRESSION; WESTERN BLOTTING;

BIOSENSING TECHNIQUES; CELL DIVISION; CULTURE MEDIA; DNA, MITOCHONDRIAL; ENERGY METABOLISM; GALACTOSE; GLUCOSE; GLYCOLYSIS; HELA CELLS; HEXOKINASE; HUMANS; HYDROGEN-ION CONCENTRATION; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MONOSACCHARIDE TRANSPORT PROTEINS; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION;

EID: 0842325793     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-1101     Document Type: Article

References (51)

1. Griffiths, J. R. Causes and consequences of hypoxia and acidity in tumour microenvironments. Bioessays, 23: 295-296, 2001.
2. Reitzer, L., Wice, B., and Kennel, D. Evidence that glutamine, not sugar, is the major energy source for cultured Hela cells. J. Biol. Chem., 254: 2669-2676, 1979.
3. Warburg, O. Metabolism of Tumors. London: Arnold Constable, 1930.
4. Pedersen, P. Tumor mitochondria and the bioenergetic of cancer cells. In: J. R. Bertino (ed.), Progress in Experimental Tumor Research, Vol. 22, pp. 190-274. New York: Karger, 1978.
5. Cuezva, J. M. K. M., de Heredia, M. L., Krajewski, S., Santamaria, G., Kim, H., Zapata, J. M., Marusawa, H., Chamorro, M., and Reed, J. C. The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res., 62: 6674-6681, 2002.
6. Springer, E. Comparative study of the cytoplasmic organelles of epithelial cell lines derived from human carcinomas and nonmalignant tissues. Cancer Res., 40: 803-817, 1980.
7. Hoberman, H. Is there a role for mitochondrial genes in carcinogenesis? Cancer Res., 35: 3332-3335, 1975.
8. Simonnet, H., Alazard, N., Pfeiffer, K., Gallou, C., Beroud, C., Demoni, J., Bouvier, R., Schagger, H., and Godinot, C. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis (Lond.), 23: 759-768, 2002.
9. Irwin, C., Malkin, L., and Morris, H. Differences in total mitochondrial proteins and proteins synthesized by mitochondria from rat liver and Morris hepatomas 9618A, 5123C, and 5123tc. Cancer Res., 38: 1584-1588, 1978.
10. Senior, A., McGowan, S., and Hilf, R. A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland. Cancer Res., 35: 2061-2067, 1975.
11. Stocco, D., and Hutson, J. Characteristics of mitochondria isolated by rate zonal centrifugation from normal liver and Novikoff hepatomas. Cancer Res., 40: 1486-1492, 1980.
12. Boitier, E., Merad-Boudia, M., Guguen-Guillouzo, C., Defer, N., Ceballos-Picot, I., Leroux, J., and Marsac, C. Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals. Cancer Res., 55: 3028-3035, 1995.
13. Weber, K., Ridderskamp, D., Alfert, M., Hoyer, S., and Wiesner, R. J. Cultivation in glucose-deprived medium stimulates mitochondrial biogenesis and oxidative metabolism in HepG2 hepatoma cells. Biol Chem., 383: 283-290, 2002.
14. Eigenbrodt, E., Kallinowski, F., Ott, M., Mazurek, S., and Vaupel, P. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Res., 18: 3267-3274, 1998.
15. Huseby, R. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression. Cancer Res., 43: 5365-5378, 1983.
16. Thakar, J., Chapin, C., Berg, R., Ashmun, R., and Houghton, P. Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions. Cancer Res., 51: 6286-6291, 1991.
17. Nagino, M., Tanaka, M., Nishikimi, M., Nimura, Y., Kubota, H., Kanai, M., Kato, T., and Ozawa, T. Stimulated rat liver mitochondrial biogenesis after partial hepatectomy. Cancer Res., 49: 4913-4918, 1989.
18. Elsliger, M. A., Wachter, R. M., Hanson, G. T., Kallio, K., and Remington, S. J. Structural and spectral response of green fluorescent protein variants to changes in pH. Biochemistry, 38: 5296-301, 1999.
19. Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G., and Tsien, R. Y. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl. Acad. Sci. USA, 95: 6803-6808, 1998.
20. Hanson, G. T., Aggeler, R., Oglesbee, D., Capaldi, R. A., Tsien, R. Y., and Remington, S. J. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem., in press, 2004.
21. Ostergaard, H., Henriksen, A., Hansen, F. G., and Winther, J. R. Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein. EMBO J., 20: 5853-5862, 2001.
22. Hanson, B., Marusich, M., and Capaldi, R. antibody-based approaches to diagnosis and characterization of oxidative phosphorylation diseases. Mitochondrion, 1: 237-248, 2001.
23. Triepels, R., Hanson, B., van den Heuvel, L., Sundell, L., Marusich, M., Smeitink, J., and Capaldi, R. Human complex 1 defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J. Biol. Chem., 276: 8892-8897, 2001.
24. Holland, P. M., Abramson, R. D., Watson, R., and Gelfand, D. H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA, 88: 7276-7280, 1991.
25. Hackenbrock, C. R., Rehn, T. G., Weinbach, E. C., and Lemasters, J. J. Oxidative phosphorylation and ultrastructural transformation in mitochondria in the intact ascites tumor cell. J. Cell Biol., 51: 123-137, 1971.
26. Donnely, M., and Scheffler, I. Energy metabolism in respiration deficient and wildtype Chinese hamster fibroblasts in culture. J. Cell. Physiol., 89: 39-52, 1976.
27. Grynkiewicz, G, Poenie, M., and Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260: 3440-3450, 1985.
28. Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., and Reed, J. C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat. Cell Biol., 2: 318-325, 2000.
29. Takahashi, A., Zhang, Y., Centonze, E., and Herman, B. Measurement of mitochondrial pH in situ. Biotechniques, 30: 804-808, 810, 812 passim, 2001.
30. Chance, B., and Williams, G. R. The respiratory chain and oxidative phosphorylation. Adv. Enzymol., 17: 65-134, 1956.
31. Nicholls, D. G. The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. Eur. J. Biochem., 50: 305-315, 1974.
32. Rottenberg, H. The measurement of transmembrane electrochemical proton gradients. J. Bioenerg., 7: 61-74, 1975.
33. Davis, M. H., Altschuld, R. A., Jung, D. W., and Brierley, G. P. Estimation of intramitochondrial pCa and pH by fura-2 and 2, 7 biscarboxyethyl-5(6)-carboxyfluorescein (BCECF) fluorescence. Biochem. Biophys. Res. Commun., 149: 40-45, 1987.
34. Seo, M. S., Kang, S. W., Kim, K., Baines, I. C., Lee, T. H., and Rhee, S. G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem., 275: 20346-54, 2000.
35. Robinson, B. Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. Method. Enzymol., 264: 455-464, 1996.
36. John, A. P. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. Med. Hypotheses, 57: 429-431, 2001.
37. Cuezva, J. M., Ostronoff, L. K., Ricart, J., Lopez de Heredia, M., Di Liegro, C. M., and Izquierdo, J. M. Mitochondrial biogenesis in the liver during development and oncogenesis. J. Bioenerg. Biomembr., 29: 365-377, 1997.
38. Singh, K. K., Russell, J., Sigala, B., Zhang, Y., Williams, J., and Keshav, K. F. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene, 18: 6641-6646, 1999.
39. Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K., Markowitz, S. D., Trush, M. A., Kinzler, K. W., and Vogelstein, B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet., 20: 291-293, 1998.
40. Pedersen, P. L., Mathupala, S., Rempel, A., Geschwind, J. F., and Ko, Y. H. Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim. Biophys. Acta, 1555: 14-20, 2002.
41. Helmlinger, G. S. A., Dellian, M., Forbes, N. S., and Jain, R. K. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res., 8: 1284-1291, 2002.
42. Bereiter-Hahn, J., and Voth, M. Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc. Res. Tech., 27: 198-219, 1994.
43. Rizzuto, R., Brini, M., De Giorgi, F., Rossi, R., Heim, R., Tsien, R. Y. and Pozzan, T. Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr. Biol., 6: 183-188, 1996.
44. Frey, T. G., and Mannella, C. A. The internal structure of mitochondria. Trends Biochem. Sci., 25: 319-324, 2000.
45. Gilkerson, R. W., Margineantu, D. H., Capaldi, R. A., and Selker, J. M. Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cells. FEBS Lett., 474: 1-4, 2000.
46. Gilkerson, R. W., Selker, J. M., and Capaldi, R. A. The cristal membrane of mitochondria is the principal site of oxidative phosphorylation. FEBS Lett., 546: 355-358, 2003.
47. Hackenbrock, C. R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in isolated liver mitochondria. J. Cell Biol., 30: 269-297, 1966.
48. Hackenbrock, C. R. Ultrastructural bases for metabolically linked mechanical activity in mitochondria. II. Electron transport-linked ultrastructural transformations in mitochondria. J. Cell Biol., 37: 345-369, 1968.
49. Reichmann, H., Vogler, L., and Seibel, P. Ragged red or ragged blue fibers. Eur. Neurol., 36: 98-102, 1996.
50. Mazurek, S., Zwerschke, W., Jansen-Durr, P., and Eigenbrodt, E. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene, 20: 6891-6898, 2001.
51. Taylor, R. W., Wardell, T. M., Smith, P. M., Muratovska, A., Murphy, M. P., Turnbull, D. M., and Lightowlers, R. N. An antigenomic strategy for treating heteroplasmic mtDNA disorders. Adv. Drug Deliv. Rev., 49: 121-125, 2001.